The USPSTF's downgrade of prostate cancer screening to a "D" recommendation at this time is irresponsible and inexplicable. It even would deny screening to those at the greatest risk for prostate cancer— African-Americans and those with a family history of prostate cancer. These patients urgently need to be educated about their risks of developing cancer, and the role that screening could play in early diagnosis and treatment.
"The recommendation not only grossly misrepresents the current literature about screening, but makes a blanket statement about what's right for all men," said Kapoor. "Every man has a right to make his own decision about screening after discussion with his own doctor. We cannot allow an unaccountable government entity to deny patients access to tests that saves the lives of thousands of Americans every year."
LUGPA joins the American Urological Association (AUA) and the American Association of Clinical Urologists (AACU) in support of PSA screening for well-informed men who wish to pursue early diagnosis for a disease that is the second leading cause of cancer death in men. The USPSTF's recommendations risk undoing 20 years of progress in patient education and puts the lives of tens of thousands of men at risk. All concerned citizens are encouraged to contact government representatives to demand the government not restrict access to this life-saving testing as a result of misguided recommendations.
Please visit LUGPA's website for additional information on PSA screening.
LUGPA represents 95 large urology group practices in the United States, with more than 1,800 physicians who make up more than 20 percent of the nation's practicing urologists. LUGPA and its member practices are committed to best practices, research, data collection, and benchmarking to promote qual
|SOURCE Large Urology Group Practice Association|
Copyright©2010 PR Newswire.
All rights reserved